Erratum to "Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency" [Mol. Genet. Metabol. 90/4 (2007) 414-421] (DOI:10.1016/j.ymgme.2006.12.005);Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency

Molecular Genetics and Metabolism

Volumn 90, Issue 4, 2007, Pages 414-421

  Wilson, Robert C ^a   Nimkarn, Saroj ^a   Dumic, Miro ^b   Obeid, Jihad ^a,c   Azar, Maryam ^d   Najmabadi, Hossein ^d   Saffari, Fatemeh ^d   New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b KBC Zagreb   (Croatia)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; CYP21A2; Steroidogenesis

Indexed keywords

CYTOCHROME P450 2A1;

ADULT; ALLELE; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CROATIA; ESKIMO; ETHNICITY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PEDIGREE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; UNITED STATES;

EID: 33947592785     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.12.013     Document Type: Erratum

References (52)

1. White P.C., New M.I., and Dupont B. Molecular cloning of steroid 21-hydroxylase. Ann. N. Y. Acad. Sci. 458 (1985) 277-287
2. White P.C., New M.I., and Dupont B. Structure of the human steroid 21-hydroxylase genes. Proc. Natl. Acad. Sci. USA 83 (1986) 5111-5115
3. Higashi Y., Yoshioka H., Yamane M., Gotoh O., and Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc. Natl. Acad. Sci. USA 83 (1986) 2841-2845
4. Urban M.D., Lee P.A., and Migeon C.J. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N. Engl. J. Med. 299 (1978) 1392-1396
5. Clark R.V., Albertson B.D., Munabi A., Cassorla F., Aguilera G., Warren D.W., Sherins R.J., and Loriaux D.L. Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 70 (1990) 1408-1413
6. Srikanth M.S., West B.R., Ishitani M., Isaacs Jr. H., Applebaum H., and Costin G. Benign testicular tumors in children with congenital adrenal hyperplasia. J. Pediatr. Surg. 27 (1992) 639-641
7. Premawardhana L.D., Hughes I.A., Read G.F., and Scanlon M.F. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin. Endocrinol. (Oxford) 46 (1997) 327-332
8. New M.I., and Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. USA 96 (1999) 12790-12797
9. New M.I. Extensive personal experience: Nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91 (2006) 4205-4214
10. New M.I., Lorenzen F., Lerner A.J., Kohn B., Oberfield S.E., Pollack M.S., Dupont B., Stoner E., Levy D.J., Pang S., and Levine L.S. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J. Clin. Endocrinol. Metab. 57 (1983) 320-326
11. Lundin G., Wedell A., Thunell S., and Anvret M. Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR amplification of specific alleles. Hum. Genet. 93 (1994) 59-62
12. White P., and Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21 (2000) 245-291
13. Olney R., Mougey E., Wang J., Shulman D., and Sylvester J. Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population. J. Clin. Endocrinol. Metab. 87 (2002) 735-741
14. Baumgartner-Parzer S.M., Schulze E., Waldhausl W., Pauschenwein S., Rondot S., Nowotny P., Meyer K., Frisch H., Waldhauser F., and Vierhapper H. Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation. J. Clin. Endocrinol. Metab. 86 (2001) 4771-4775
15. Wilson R.C., Wei J.Q., Cheng K.C., Mercado A.B., and New M.I. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J. Clin. Endocrinol. Metab. 80 (1995) 1635-1640
16. Wilson R.C., Mercado A.B., Cheng K.C., and New M.I. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J. Clin. Endocrinol. Metab. 80 (1995) 2322-2329
17. Pang S.Y., Wallace M.A., Hofman L., Thuline H.C., Dorche C., Lyon I.C., Dobbins R.H., Kling S., Fujieda K., and Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81 (1988) 866-874
18. Pang S., and Clark A. Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Trends Endocrinol. Metab. 1 (1990) 300-307
19. van der Kamp H.J., and Wit J.M. Neonatal screening for congenital adrenal hyperplasia. Eur. J. Endocrinol. 151 Suppl. 3 (2004) U71-U75
20. Mikami A., Fukushi M., Oda H., Fujita K., and Fujieda K. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience. Southeast Asian J. Trop. Med. Public Health. 30 Suppl. 2 (1999) 100-102
21. Cutfield W.S., and Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J. Pediatr. 126 (1995) 118-121
22. Speiser P.W., Dupont B., Rubinstein P., Piazza A., Kastelan A., and New M.I. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37 (1985) 650-667
23. Lee H.H., Kuo J.M., Chao H.T., Lee Y.J., Chang J.G., Tsai C.H., and Chung B.C. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J. Clin. Endocrinol. Metab. 85 (2000) 597-600
24. Tusie-Luna M.T., Speiser P.W., Dumic M., New M.I., and White P.C. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol. Endocrinol. 5 (1991) 685-692
25. White P.C., Vitek A., Dupont B., and New M.I. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85 (1988) 4436-4440
26. White P.C., New M.I., and Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc. Natl. Acad. Sci. USA 81 (1984) 7505-7509
27. Higashi Y., Tanae A., Inoue H., and Fujii-Kuriyama Y. Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 42 (1988) 17-25
28. Tusie-Luna M.T., and White P.C. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc. Natl. Acad. Sci. USA 92 (1995) 10796-10800
29. Higashi Y., Tanae A., Inoue H., Hiromasa T., and Fujii-Kuriyama Y. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc. Natl. Acad. Sci. USA 85 (1988) 7486-7490
30. Amor M., Parker K.L., Globerman H., New M.I., and White P.C. Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85 (1988) 1600-1604
31. Tusie-Luna M., Traktman P., and White P.C. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J. Biol. Chem. 265 (1990) 20916-20922
32. Helmberg A., Tusie-Luna M.-T., Tabarelli M., Kofler R., and White P.C. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions. Mol. Endocrinol. 6 (1992) 1318-1322
33. Dumic M., Brkljacic L., Plavsic V., Zunec R., Ille J., Wilson R.C., Kuvacic I., Kastelan A., and New M.I. Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia. Am. J. Med. Genet. 72 (1997) 302-306
34. Dumic M., Ille J., Zunec R., Plavsic V., Francetic I., Skrabic V., Janjanin N., Spehar A., Wei J., Wilson R.C., and New M.I. Nonclassic 21-hydroxylase deficiency in Croatia. J. Pediatr. Endocrinol. Metab. 17 (2004) 157-164
35. Speiser P.W., New M.I., Tannin G.M., Pickering D., Yang S.Y., and White P.C. Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Genet. 88 (1992) 647-648
36. Mercado A.B., Wilson R.C., Cheng K.C., Wei J.Q., and New M.I. Extensive personal experience: prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80 (1995) 2014-2020
37. Tukel T., Uyguner O., Wei J.Q., Yuksel-Apak M., Saka N., Song D.X., Kayserili H., Bas F., Gunoz H., Wilson R.C., New M.I., and Wollnik B. A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 88 (2003) 5893-5897
38. Stenson P.D., Ball E.V., Mort M., Phillips A.D., Shiel J.A., Thomas N.S., Abeysinghe S., Krawczak M., and Cooper D.N. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat. 21 (2003) 577-581
39. Balsamo A., Cacciari E., Baldazzi L., Tartaglia L., Cassio A., Mantovani V., Piazzi S., Cicognani A., Pirazzoli P., Mainetti B., and Zappulla F. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin. Endocrinol. (Oxford) 53 (2000) 117-125
40. Vakili R., Baradaran-Heravi A., Barid-Fatehi B., Gholamin M., Ghaemi N., and Abbaszadegan M.R. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran. Horm. Res. 63 (2005) 119-124
41. Mathur R., Menon P.S., Kabra M., Goyal R.K., and Verma I.C. Molecular characterization of mutations in Indian children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J. Pediatr. Endocrinol. Metab. 14 (2001) 27-35
42. Barbat B., Bogyo A., Raux-Demay M.C., Kuttenn F., Boue J., Simon-Bouy B., Serre J.L., and Mornet E. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum. Mutat. 5 (1995) 126-130
43. Deneux C., Tardy V., Dib A., Mornet E., Billaud L., Charron D., Morel Y., and Kuttenn F. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 86 (2001) 207-213
44. Mornet E., Crete P., Kuttenn F., Raux-Demay M.C., Boue J., White P.C., and Boue A. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 48 (1991) 79-88
45. Pinto G., Tardy V., Trivin C., Thalassinos C., Lortat-Jacob S., Nihoul-Fekete C., Morel Y., and Brauner R. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. J. Clin. Endocrinol. Metab. 88 (2003) 2624-2633
46. Speiser P.W., Dupont J., Zhu D., Serrat J., Buegeleisen M., Tusie L.M., Lesser M., New M.I., and White P.C. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Invest. 90 (1992) 584-595
47. Higashi Y., Hiromasa T., Tanae A., Miki T., Nakura J., Kondo T., Ohura T., Ogawa E., Nakayama K., and Fujii K.Y. Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J. Biochem. 109 (1991) 638-644
48. Buchner D.A., Trudeau M., and Meisler M.H. SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science 301 (2003) 967-969 1126/science.1086187
49. White P.C., Tusie-Luna M.T., New M.I., and Speiser P.W. Mutations in steroid 21-hydroxylase (CYP21). Hum. Mutat. 3 (1994) 373-378
50. Speiser P.W., New M.I., and White P.C. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N. Engl. J. Med. 319 (1988) 19-23
51. Globerman H., Amor M., Parker K.L., New M.I., and White P.C. Nonsense mutation causing steroid 21-hydroxylase deficiency. J. Clin. Invest. 82 (1988) 139-144
52. Chiou S.H., Hu M.C., and Chung B.C. A missense mutation at Ile172-Asn or Arg356-Trp causes steroid 21-hydroxylase deficiency. J. Biol. Chem. 265 (1990) 3549-3552